ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Lombardi Cancer Center, UDC Collaborate to Increase Cancer Awareness Among Blacks

August 3, 2001

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

In Brief: Emory Univ. Receives $295 Million Endowment; Winship Cancer Center To Get Half of Income

August 16, 1996

Larynx Preservation Provides Better Voice Quality For Patients

February 29, 2008

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986